revenue growth

SaaS stocks down 24% YTD amid valuation concerns, but companies like Figma and Axon show resilience with strong revenue growth and AI expansion despite sector weakness.

Amplitude stock drops 41% despite strong 17% revenue growth, record cash flow, and new AI analytics platform launch.

Nvidia exceeded Q4 expectations with $68.1B revenue and projects $78B for Q1 2027, signaling sustained AI demand and strong growth momentum.

Nvidia reports record $68B revenue, up 73% YoY, driven by surging data center AI demand. Company guides $78B next quarter, projecting sustained AI infrastructure growth.

Climb Global Solutions reports 40% revenue growth in 2025, reaching $652.5M. The company suspended dividends and acquired Interworks to fund future growth opportunities.

Arcutis reported 2025 revenue of $372.1M (123% growth) and raised 2026 guidance to $480-495M, driven by strong ZORYVE adoption and positive clinical data.

HSBC shares hit 52-week peak after strong Q4 earnings beat. Bank reported 42% revenue growth and exceeded profit expectations, boosting investor confidence.

Immuron lifted H1 revenue 5% to AUD$4.2M with strong U.S. growth of 17%. The company secured AUD$7.3M funding and is pursuing partnerships to advance its clinical pipeline.

Carvana stock dropped 10% post-earnings as profitability concerns persist despite 58% revenue growth. Compressed margins and missed EBITDA expectations weigh on investor sentiment.

Rocket Lab reports earnings February 26 with 80% of prediction market participants expecting beat. Stock movement likely hinges on Neutron rocket timeline guidance rather than financial results.

1492 Capital acquires 215,987 shares of Applied Optoelectronics for $7.53 million, making it their third-largest holding, betting on AI-driven data center demand.

Alphabet's diversified revenue streams, including Google Cloud and AI services, outpace Meta's reliance on advertising for 98% of revenue, reducing long-term risk exposure.

Day One Biopharmaceuticals reports 172% revenue growth to $155.4M, driven by OJEMDA sales strength. Company acquires Mersana Therapeutics to expand pipeline.

American Sports shares dropped 4.42% despite beating Q4 earnings, as weak 2026 guidance disappointed investors seeking stronger growth outlook.

TSM reports record financial performance driven by AI chip demand, with revenue up 350% and gross margins near 60%. AI chips now represent 58% of revenue.

Morgan Stanley cuts IonQ price target from $58 to $35 ahead of Q4 results, citing technical challenges and profitability concerns despite strong revenue growth.

Figma rebounds on strong 41% revenue growth and positive free cash flow, but valuation concerns persist as stock remains 80% below IPO price amid profitability questions.

AI-driven insurer Lemonade stock drops below $60 amid market volatility, but 40% revenue growth and strong customer expansion suggest potential investment opportunity.

Tradewinds expands nightlife portfolio through Peppermint Hippo integration, targeting $40M+ revenue in 2026 across Florida, Louisiana, and Texas with long-term 100-venue goal.

Truist plans 4-5% revenue growth through loan expansion and margin improvement, while returning $4 billion via share buybacks alongside dividends.